| Issue Date | Title | Author(s) | Source | scopus | WOS | Fulltext/Archive link |
| 2018 | 14 Day sequential therapy versus 10 day bismuth quadruple therapy containing high-dose esomeprazole in the first-line and second-line treatment of Helicobacter pylori: A multicentre, non-inferiority, randomized trial | JYH-MING LIOU ; CHIEH-CHANG CHEN ; YU-JEN FANG ; Chen P.-Y.; Chang C.-Y.; Chou C.-K.; Chen M.-J.; Tseng C.-H.; Lee J.-Y.; Yang T.-H.; Chiu M.-C.; Yu J.-J.; Kuo C.-C.; Luo J.-C.; WEN-FENG HSU ; Hu W.-H.; Tsai M.-H.; Lin J.-T.; CHIA-TUNG SHUN ; Twu G.; YI-CHIA LEE ; Bair M.-J.; MING-SHIANG WU ; Taiwan Gastrointestinal Disease and Helicobacter Consortium; Helicobacter Consortium | Journal of Antimicrobial Chemotherapy | 10 | 11 | |
| 2020 | Accuracy of rapid Helicobacter pylori antigen tests for the surveillance of the updated prevalence of H. pylori in Taiwan | YU-JEN FANG ; Chen M.-J.; CHIEH-CHANG CHEN ; Lee J.-Y.; Yang T.-H.; Yu C.-C.; Chiu M.-C.; Kuo C.-C.; Weng Y.-J.; Bair M.-J.; MING-SHIANG WU ; Luo J.-C.; JYH-MING LIOU | Journal of the Formosan Medical Association | 8 | 6 | |
| 2020 | Application of Helicobacter pylori stool antigen test to survey the updated prevalence of Helicobacter pylori infection in Taiwan | Chen M.-J.; YU-JEN FANG ; MING-SHIANG WU ; CHIEH-CHANG CHEN ; YEN-NIEN CHEN ; Yu C.-C.; Kuo C.-C.; Chiu M.-C.; Hu W.-H.; Tsai M.-H.; Hsieh C.-L.; Chen H.-H.; Bair M.-J.; JYH-MING LIOU ; for the Taiwan Gastrointestinal Disease; Helicobacter Consortium | Journal of Gastroenterology and Hepatology (Australia) | 9 | 6 | |
| 2016 | Association Between Serum Level of Hepatitis B Surface Antigen at End of Entecavir Therapy and Risk of Relapse in E Antigen–Negative Patients | Hsu Y.-C.; Mo L.-R.; Chang C.-Y.; MING-SHIANG WU ; JIA-HORNG KAO ; Wang W.-L.; Yang T.-H.; Wang C.-S.; Chiang M.-F.; CHIEH-CHANG CHEN ; YU-JEN FANG ; Hung H.-W.; Wu C.-Y.; Lin J.-T. | Clinical Gastroenterology and Hepatology | 30 | 29 | |
| 2009 | Barium appendicitis | YU-JEN FANG ; HSIU-PO WANG ; CHENG-MAW HO ; KAO-LANG LIU | Surgery | 10 | 12 | |
| 2021 | Community-Based Gastric Cancer Screening Coupled With a National Colorectal Cancer Screening Program: Baseline Results | YI-CHIA LEE ; TSUNG-HSIEN CHIANG ; HAN-MO CHIU ; MING-SHIANG WU ; Yeh, Yen-Po; Hsiu-Hsi Chen, Tony; Li-Sheng Chen S.; Ming-Fang Yen A.; Ching-Yuan Fann J.; Yueh-Hsia Chiu S.; Hsu C.-Y.; Chuang S.-L.; Chou K.-C.; Su W.-W.; Chen S.-T.; Liao C.-S.; Lin Y.-M.; Chang H.-C.; Hu T.-H.; YU-JEN FANG ; CHANG-CHUAN CHAN ; Collaborators of the Taiwan Community-Based Integrated Screening Group | Gastroenterology | 5 | 4 | |
| 2020 | Comparison of DNA stabilizers and storage conditions on preserving fecal microbiota profiles | CHIEH-CHANG CHEN ; WEI-KAI WU ; Chang, Chih-Min; Panyod, Suraphan; TZU-PIN LU ; JYH-MING LIOU ; YU-JEN FANG ; ERIC YAO-YU CHUANG ; MING-SHIANG WU | Journal of the Formosan Medical Association = Taiwan yi zhi | | 9 | |
| 2020 | Comparison of the effect of clarithromycin triple therapy with or without N-acetylcysteine in the eradication of Helicobacter pylori: a randomized controlled trial | CHIEH-CHANG CHEN ; Luo J.-C.; YU-JEN FANG ; Lee J.-Y.; Kuo C.-C.; Yang T.-H.; Chiu M.-C.; Yu J.-J.; Bair M.-J.; Chen P.-Y.; Chou C.-K.; Chen C.-Y.; Chang C.-Y.; Hsu Y.-C.; Tseng C.-H.; WEN-FENG HSU ; Hu W.-H.; Tsai M.-H.; Hsieh C.-L.; Chen M.-J.; CHIA-TUNG SHUN ; Liu T.-Y.; YI-CHIA LEE ; Liou§ J.-M.; MING-SHIANG WU ; and for the Taiwan Gastrointestinal Disease and Helicobacter Consortium; Helicobacter Consortium | Therapeutic Advances in Gastroenterology | 5 | 5 | |
| 2012 | Computer-generated surface and tone enhancements to distinguish neoplastic from non-neoplastic colon polyps less than 1 cm in diameter | MING-LUN HAN ; YI-CHIA LEE ; CHIEH-CHANG CHEN ; YU-JEN FANG ; Lee J.-Y.; Lin T.-L.; Lin L.-W.; PING-HUEI TSENG ; MING-SHIANG WU ; HSIU-PO WANG | International Journal of Colorectal Disease | 4 | 3 | |
| 2016 | Concomitant, bismuth quadruple, and 14-day triple therapy in the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trial | JYH-MING LIOU ; YU-JEN FANG ; CHIEH-CHANG CHEN ; Bair M.-J.; Chang C.-Y.; YI-CHIA LEE ; Chen M.-J.; CHIEH-CHANG CHEN ; Tseng C.-H.; Hsu Y.-C.; Lee J.-Y.; Yang T.-H.; Luo J.-C.; Chang C.-C.; Chen C.-Y.; Chen P.-Y.; CHIA-TUNG SHUN ; WEN-FENG HSU ; Hu W.-H.; YEN-NIEN CHEN ; Sheu B.-S.; Lin J.-T.; Wu J.-Y.; El-Omar E.M.; MING-SHIANG WU ; Taiwan Gastrointestinal Disease and Helicobacter Consortium; Helicobacter Consortium | The Lancet | 95 | 90 | |
| 2022 | Declining trends of prevalence of Helicobacter pylori infection and incidence of gastric cancer in Taiwan: An updated cross-sectional survey and meta-analysis | Chen, Mei-Jyh; Bair, Ming-Jong; Chen, Po-Yueh; Lee, Ji-Yuh; Yang, Tsung-Hua; YU-JEN FANG ; CHIEH-CHANG CHEN ; Chang, An-Ti; Hsiao, Wang-De; Yu, Jian-Jyun; Kuo, Chia-Chi; Chiu, Min-Chin; Lin, Kun-Pei; Tsai, Min-Horn; Hsu, Yao-Chun; Chou, Chu-Kuang; Chen, Chi-Yi; Lin, Jaw-Town; YI-CHIA LEE ; MING-SHIANG WU ; JYH-MING LIOU ; forthe Taiwan Gastrointestinal Disease; Helicobacter Consortium | Helicobacter | 2 | 2 | |
| 2015 | Distinct aetiopathogenesis in subgroups of functional dyspepsia according to the Rome III criteria | YU-JEN FANG ; JYH-MING LIOU ; CHIEH-CHANG CHEN ; Lee J.-Y.; Hsu Y.-C.; Chen M.-J.; PING-HUEI TSENG ; CHIEH-CHANG CHEN ; Chang C.-Y.; Yang T.-H.; Chang W.-H.; Wu J.-Y.; HSIU-PO WANG ; Luo J.-C.; Lin J.-T.; CHIA-TUNG SHUN ; MING-SHIANG WU | Gut | 59 | 49 | |
| 2018 | Efficacies of Genotypic Resistance-Guided vs Empirical Therapy for Refractory Helicobacter pylori Infection | Liou J.-M.; Chen P.-Y.; Luo J.-C.; Lee J.-Y.; CHIEH-CHANG CHEN ; YU-JEN FANG ; Yang T.-H.; Chang C.-Y.; Bair M.-J.; Chen M.-J.; Hsu Y.-C.; WEN-FENG HSU ; Chang C.-C.; Lin J.-T.; CHIA-TUNG SHUN ; El-Omar E.M.; MING-SHIANG WU ; Liou J.-M.; YI-CHIA LEE ; Lin J.-T.; Wu C.-Y.; Wu J.-Y.; CHIEH-CHANG CHEN ; Lin C.-H.; Fang Y.-R.; Bair M.-J.; Luo J.-C.; TSU-YAO CHENG ; PING-HUEI TSENG ; HAN-MO CHIU ; Chang C.-C.; Yu C.-C.; Chiu M.-C.; YEN-NIEN CHEN ; Hu W.-H.; Chou C.-K.; Tai C.-M.; Lee C.-T.; Wang W.-L.; Chang W.-S.; Taiwan Gastrointestinal Disease and Helicobacter Consortium; Helicobacter Consortium | Gastroenterology | 47 | 22 | |
| 2013 | Efficacy of genotypic resistance-guided sequential therapy in the third-line treatment of refractory Helicobacter pylori infection: A multicentre clinical trial | JYH-MING LIOU ; CHIEH-CHANG CHEN ; Chang C.-Y.; Chen M.-J.; YU-JEN FANG ; Lee J.-Y.; CHIEH-CHANG CHEN ; Hsu S.-J.; Hsu Y.-C.; Tseng C.-H.; PING-HUEI TSENG ; Chang L.; Chang W.-H.; HSIU-PO WANG ; CHIA-TUNG SHUN ; Wu J.-Y.; YI-CHIA LEE ; Lin J.-T.; MING-SHIANG WU ; Lin C.-H.; Chow L.-P.; TSU-YAO CHENG ; Wu C.-Y.; Lee Ching-Tai C.-T, Wang W.-L.; Tai C.-M.; Wang Y.-C.; CHIH-HSIEN WANG ; Kuo S.-H.; Wu C.-Y. | Journal of Antimicrobial Chemotherapy | 69 | 65 | |
| 2021 | The efficacy of Lactobacillus acidophilus and rhamnosus in the reduction of bacterial load of Helicobacter pylori and modification of gut microbiota—a double-blind, placebo-controlled, randomized trial | Chen M.-J.; CHIEH-CHANG CHEN ; Huang Y.-C.; Tseng C.-C.; Hsu J.-T.; Lin Y.-F.; YU-JEN FANG ; MING-SHIANG WU ; JYH-MING LIOU ; for the Taiwan Gastrointestinal Disease, Helicobacter Consortium | Helicobacter | 6 | 5 | |
| 2020 | Elbasvir/grazoprevir for hepatitis C virus genotype 1b East-Asian patients receiving hemodialysis | CHEN-HUA LIU ; Peng C.-Y.; YU-JEN FANG ; Kao W.-Y.; Yang S.-S.; Lin C.-K.; Lai H.-C.; Su W.-P.; Fang S.-U.; Chang C.-C.; TUNG-HUNG SU ; CHUN-JEN LIU ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Scientific Reports | 5 | 4 | |
| 2011 | Empirical modified sequential therapy containing levofloxacin and high-dose esomeprazole in second-line therapy for Helicobacter pylori infection: A multicentre clinical trial | JYH-MING LIOU ; CHIEH-CHANG CHEN ; Chen M.-J.; Chang C.-Y.; YU-JEN FANG ; Lee J.-Y.; WANG-HUEI SHENG ; HSIU-PO WANG ; MING-SHIANG WU ; Lin J.-T. | Journal of Antimicrobial Chemotherapy | 39 | 39 | |
| 2017 | Hepatitis B virus reactivation in patients receiving interferon-free direct-acting antiviral agents for chronic hepatitis C virus infection | CHEN-HUA LIU ; CHUN-JEN LIU ; TUNG-HUNG SU ; YU-JEN FANG ; HUNG-CHIH YANG ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Open Forum Infectious Diseases | 39 | 38 | |
| 2017 | Impact of amoxicillin resistance on the efficacy of amoxicillincontaining regimens for Helicobacter pylori eradication: Analysis of five randomized trials | Chen M.-J.; MING-SHIANG WU ; CHIEH-CHANG CHEN ; CHIEH-CHANG CHEN ; YU-JEN FANG ; Bair M.-J.; Chang C.-Y.; Lee J.-Y.; WEN-FENG HSU ; Luo J.-C.; Lin J.-T.; JYH-MING LIOU ; on behalf of the Taiwan Gastrointestinal Disease; Helicobacter Consortium | Journal of Antimicrobial Chemotherapy | 14 | 13 | |
| 2016 | Levofloxacin sequential therapy vs levofloxacin triple therapy in the second-line treatment of helicobacter pylori: A randomized trial | JYH-MING LIOU ; Bair M.-J.; CHIEH-CHANG CHEN ; YI-CHIA LEE ; Chen M.-J.; CHIEH-CHANG CHEN ; Tseng C.-H.; YU-JEN FANG ; Lee J.-Y.; Yang T.-H.; Luo J.-C.; Wu J.-Y.; Chang W.-H.; Chang C.-C.; Chen C.-Y.; Chen P.-Y.; CHIA-TUNG SHUN ; WEN-FENG HSU ; Hung H.-W.; Lin J.-T.; Chang C.-Y.; MING-SHIANG WU | American Journal of Gastroenterology | 34 | 32 | |
